Semarion is an advanced materials company spun out from the Cavendish Laboratory in Cambridge. Our mission is to accelerate in vitro drug discovery by supercharging adherent cell assays to produce better data faster. Our proprietary SemaCyte® microcarrier platform leverages novel materials physics to barcode, move, and freeze adherent cells. We introduce flexibility, miniaturisation, and multiplexing into existing drug discovery workflows to deliver 10x gains in data.
Our well-shaped SemaCyte microcarriers seamless integration with standard microplate workflows to supercharge cell-based assays:
- Increase Throughput: Our barcoded microcarriers enable combining diverse cell models into a single well. 2-10x less time and cost for cell panel screening.
- Enhanced Flexibility: Our approach allows assay-ready cells to be stored in cryovials, to assay within an hour of thawing. 2-20x faster data generation and reduced data variability.
- Resource Efficiency: We reduce the number of cells per well without compromising local confluency. 5-100x less cells used per assay.